U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07135453) titled 'Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines' on Aug. 14.
Brief Summary: The goal of this study is to learn whether different types of vaccines to prevent bacterial infections are able to effectively create antibodies that defend against certain types of bacteria.
We will give three different types of vaccine and evaluate the effectiveness of antibodies produced by each vaccine in killing bacteria.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Vaccine
Pneumococcal Disease
Intervention:
BIOLOGICAL: Pneumococcal Vaccine
PCV
Recruitment Status: NOT_YET_RECRU...